Evidence map›Paper›PMID 32867395›Full record

ArticleInternational journal of molecular sciences2020

Downregulation of TAP1 in Tumor-Free Tongue Contralateral to Squamous Cell Carcinoma of the Oral Tongue, an Indicator of Better Survival.

Nima Attaran, Xiaolian Gu, Philip J Coates, Robin Fåhraeus, Linda Boldrup, Torben Wilms, Lixiao Wang, Nicola Sgaramella, Katarina Zborayova, Karin Nylander

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Nima AttaranDepartment of Clinical Sciences/ENT, Umeå University, SE-901 85 Umeå, Sweden.ORCID 0000-0002-0074-0434
Xiaolian GuDepartment of Medical Biosciences, Umeå University, SE-901 85 Umeå, Sweden.ORCID 0000-0002-6574-3628
Philip J CoatesRECAMO, Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53 Brno, Czech Republic.
Robin FåhraeusInstitut de Génétique Moléculaire, Université Paris 7, Inserm UMR 1162, 750 13 Paris, France.
Linda BoldrupDepartment of Medical Biosciences, Umeå University, SE-901 85 Umeå, Sweden.
Torben WilmsDepartment of Clinical Sciences/ENT, Umeå University, SE-901 85 Umeå, Sweden.
Lixiao WangDepartment of Medical Biosciences, Umeå University, SE-901 85 Umeå, Sweden.
Nicola SgaramellaDepartment of Medical Biosciences, Umeå University, SE-901 85 Umeå, Sweden.
Katarina ZborayovaDepartment of Clinical Sciences/ENT, Umeå University, SE-901 85 Umeå, Sweden.
Karin NylanderDepartment of Medical Biosciences, Umeå University, SE-901 85 Umeå, Sweden.ORCID 0000-0002-4831-4100
Umeå University · SEInserm · FRMasaryk Memorial Cancer Institute · CZ

Funding

Cancerfonden 180542Lion's cancer research foundation 2019Ministry of health Czech Republic MMCI, 00209805Region Västerbotten 2019Umea University 2019
6 · The paper itself

Abstract

Oral cancers are surrounded by epithelium that histologically might seem normal, but genetically has aberrations. In patients with squamous cell carcinoma of the oral tongue (SCCOT), it is therefore important to study not only the tumor but also the clinically tumor-free contralateral tongue tissue that remains in the patient after treatment to map changes of prognostic and/or diagnostic value. The transporter associated with antigen processing (TAP) dimer is a key factor in the process of activating cytotoxic T cells. By downregulating the expression of TAP, tumor cells can escape cytotoxic T cell recognition. Biopsies from tumor and clinically tumor-free contralateral tongue tissue in 21 patients with SCCOT were analyzed together with tongue biopsies from 14 healthy individuals, which served as the control group. Dividing patients into

Indexed as

Down-RegulationAdultAgedAged, 80 and overATP Binding Cassette Transporter, Subfamily B, Member 2Biomarkers, TumorBiopsyCarcinoma, Squamous CellCase-Control StudiesEarly Detection of CancerFemaleGene Expression Regulation, NeoplasticHumansMaleMiddle AgedPrognosisATP Binding Cassette Transporter, Subfamily B, Member 2Biomarkers, TumorTAP1 protein, humanfield cancerizationMHC ISCCOTTAP1

Identifiers

PMID32867395
PMCPMC7503265
OpenAlexW3080982462

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.